ReviewIndian heart journal

A critical analysis of the COMPASS trial with respect to benefit-risk assessment using the numbers needed to treat: Applicability and relevance in Indian patients with stable cardiovascular disease.

P Kerkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.